| Expression pattern: |
UP |
| Associated gene: |
CANT1 |
| Associated microRNA: |
miR-1322 |
| Biological function: |
promoted proliferation, migration, sphere formation and tube formation, and inhibited apoptosis in LUAD cells; promoted tumor growth in vivo |
| Molecular mechanism: |
ceRNA mechanism: circ_0001715 sponges miR-1322 to upregulate CANT1 |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); apoptosis (inhibits); angiogenesis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RNase R Treatment; Bioinformatics Analysis; Luciferase Reporter Assay; RNA Pull-Down; Transfection; Colony Formation Assay; EdU Staining; Wound Healing Assay; Annexin V/PI Flow Cytometry; Western Blot; Tube Formation Assay; In Vivo Animal Model; IHC (Immunohistochemistry); Clinical Sample Validation |
| Clinical significance: |
High circ_0001715 expression was associated with TNM stage and lymph node metastasis of LUAD patients; proposed as an effective biomarker |
| Description: |
circ_0001715 is up-regulated in LUAD tissues and cell lines and promotes malignant phenotypes (proliferation, migration, sphere formation, and angiogenesis-related tube formation) while inhibiting apoptosis. Mechanistically, it functions as a ceRNA by sponging miR-1322 to increase CANT1, and its knockdown suppresses xenograft tumor growth. |
| Confidence score: |
0.8006 |